Categories

Above the Fold

TECH: Of geeks and grandiose misunderstandings

Writing in his blog from PC Forum, Esther Dyson’s technology conference that Dave Winer says is apparently is back “in” these days, here are some parts of what Michael Miller had to say.

Esther Dyson talking about how the health care industry showed extreme versions of many of the issues discussed earlier in the day: more information than ever, with users having to make more decisions themselves.

Scott Cook talked about the difficulty of tracking medical expenses and figuring out how much an individual owes.    He talked about Intuit’s Quicken Medical Expense Manager, and how institutions are wanting to get more data into it.  There are lots of issues about understanding the information, who owns the information etc. 

Jeffrey Rideout of Cisco talked about the problem of trying to get his employees information about their medical plans, expenses and other information.  We have a lot of problems to solve with the health care system, he said.  He said Cisco is looking on how to use its influence as major employer to help its employees navigate the system and get better care.

J.D. Kleinke of Omnimedix Institute talked about how looking at data is improving health care, and how it was important to gather more information about the health care process.  His company wants to give people personal health care records.  They want information that is private and portable.  He also operates Healthgrades – a site for getting the grades of your doctor and hospital. (Matthew’s note—not sure how JD ended up Vice Chairman there but he has been since the dark days of 2002!)

Gina Glantz from Service Employees International Union talked about how many of their members don’t have good health coverage; and how health care costs are an increasingly large issue in negotiations with employers.

The discussion talked about the need to deliver the technology in lots of places, perhaps by mobile phone.  But all seem to agree that technology has a way to help the system.

Scott Cook said “we don’t have time to wait” for a complex solution.  More people die because of medical errors caused by bad systems than from Diabetes or car accidents. We need to go after the root causes of the complex work systems and use best practices to improve this. We can’t wait for an all-encompassing technology solution, he said.

Rideout thought the personal health record was the first and easiest way to make an improvement; by getting a core set of information to people.We don’t spend enough money on IT for health care, he said. (Matthew’s retort—Well at least they’ve taught him something about marketing IT since he went to Cisco!)

People in the audience seemed particularly interested in the concept of a personal health record that you could carry around with you electronically. Both Intuit and Omnimedix said they were working on the problem.  Rideout said many doctors don’t trust this information though. Kleinke said the problem was not primarily technological, but instead was getting political agreement

I’ve remarked before how it’s incredible that really bright people from outside the industry just have no comprehension of how this business works. I can forgive Esther (and I was relatively nice about her before). Cook is selling a software program, and so if he can create a consumer market for PHRs, good luck to him — although I hope it’s a whole lot more transparent that the baffling TurboTax.But if this is reported accurately JD and Jeff Rideout, who both know plenty more about health care than the rest of the people in that room, need a good paddling if they seriously believe that portable PHRs are the best we can do as a solution for anyone apart from Quicken’s shareholders.

The only person who even appeared to be in the ball-park of defining what was wrong is the rep from the SEIU who’s noticed that health care costs are going up too fast and have been for years. No one (unless JD was transcribed wrongly about what was political) seems to have mentioned the overall access/cost/quality/practice variation problem.  Couldn’t they have got tech guru Len Schaeffer in there? At least he understands that part of the problem.

Of course as has been discussed many times by the crowd over here on THCB who do know something about this business, the broad problems with health care are a) the insurance market, b) the structure of the delivery system, c) the quality of the care delivered by that system and very lastly d) customer service. Well the portable PHR might solve some of the last issue, but that’s eventually being dealt with by the plans and providers starting to use decent CRM. So by glomming onto the portable PHR as a solution because it looks like a piece of technology that they vaguely understand, the PC Forum crowd is imitating the drunk looking for his keys under the street lamp because it was dark where he dropped them.

And unless the major issues of the health system are changed by some type of reform, all the technology and information in the world won’t make much difference.

 

 

THCB: Jobs, Jobs, Jobs

OK. I have two requests for people in slightly different parts of health care IT. Both are based on the west coast.

One is for a senior level marketing Director at a large technology company to build a health care marketing group. Needs 10+ years experience knowing health care, technology and marketing.

The other is a 9 month full-time contract as an IDX implementation consultant/manager for their enterprise wide scheduling system. If you don’t know what that means, it’s not for you!

Please email me with your details (resume/bio/experience) if you think that it might be you. And as I’ve said before feel free to write if you’re just looking but not for these in particular as I get asked a lot. Obviously everything is treated in total confidence,

 

HEALTH PLANS: Hey, wasn’t UHC supposed be nice now?

Having been the first health plan to say that it was going to stop hassling physicians back in 1999, I thought United was supposed to be behaving itself and promoting love, flowers and puppy-dogs all around with its providers. (Well apart from that quality ranking stuff in St Louis). Well apparently the answer is not exactly not exactly:

The Arizona Department of Insurance on Friday ordered United Healthcare to pay civil penalties totaling $364,750 — the largest fine in the department’s history — for violations of state insurance laws. State regulators said United Healthcare illegally denied more than 63,000 claims by doctors without receiving all of the information needed to accept or deny a claim. The company also failed to follow state laws for promptly notifying doctors and patients about about decisions and appeals, the state said. United also violated a 2002 agreement to correct previous violations, the state said.
Just a word of warning to the payers that the providers are ready to step it up, just in case you’ve got any ideas — like say insisting on proper documentation, or rewarding for quality (and punishing for the lack of it). And that if you’re going to throw stones, better make sure that you don’t live in a glasshouse yourself.
 

PHYSICIANS/HOPSITALS/INDUSTRY: Customer service: are new market entrants showing the way?

Interesting piece from a marketing consultant called Chris Bevolo from boutique firm GeigerBevolo Inc., in Minneapolis. The report looks at new entrants into health care services and responses to improve the patient experience at Mayo and Park Nicollet.

The new entrants profiled are Steve Case’s Revolution Health, Best Buy’s eq Life ( a pharmacy with manicures while you wait), and MinuteClinics (nurse practitioners in shopping malls). The choice of Revolution Health is a little off, and its attempts (as well as the track record of its advisory board)  has been well slagged off on TCHB and by Joe Paduda before. But the other two are well worthy of a look.

And the message seems to be a) provide shopping while people are waiting to see the doctor as Americans like shopping, and b) do it in Minnesota, because those Minnesotans like innovation. I actually think that Chris has missed a third option which is edutainment while patients are waiting.  But I’ll have more to say about that when I finally get around to discussing Phreesia’s in-office tablet entertainment/patient history service again.

But while I’m more than half-joking, I am full serious. The level of customer service in health care remains abysmal, and whether or not the market forces plans and providers to do something about it sooner rather than later, it surely can’t hurt for them to get out ahead of this trend.

PHARMA/POLICY: In this game of monopoly drugs the market is working, oh yes

So the new maker old off-patent drug that is needed badly but only by a few people, and for some reason isn’t in the Part D or most other private formularies “notices” that it has a monopoly. So what does it do?  It puts the price up nearly ten fold . (The drug is called Mustargen and the company is called Ovation Pharmaceuticals). And of course this behavior is matched by other companies that have monopolies bestowed by patents.

Presumably if the market price is that high on the non-patented drug some smart Indian generic will start making it and bring the price down, but that’ll take a little while. And in the meantime 5,000 patients are getting screwed to the wall.

We should have a rational debate about whether there ought to be coverage for certain drugs (and in the UK for instance there is such a debate).  But if there’s an egregious monopoly or market-distortion like this, then we know the solution, and it’s called monopsony — or, if you like, price-fixing. Of course this nation’s government doesn’t like to intervene in these types of cases even when it means a bunch of crooks steal blindly from a whole state and help push its economy (and by consequence that of the whole nation) into recession. And I suspect the people who need this drug view Ovation Pharma as Enron wearing lab coats.

But eventually if Pharma (both big and small) continues to abuse its monopoly power, there will be a predictable response. You can argue that making hay while the sun shines is Pharma’s best financial course (if not exactly its best ethical one), but I suspect that whoever sits in the C suites in New Jersey (and South San Francisco) and has to pick up the pieces under the next Democratic Administration may wish that a little restraint had been shown while that sun was shining.

PHARMA/QUALITY: New York Times discovers compliance

Says here, compliance with drug regimens is a big problem. (Adopt Harry Shearer voice with hard “en” sound in “knew”)”

Who knew? Who knew?

And McKesson, plus a boat load of other DM, PBM and pharma-related companies (like Pfizer Health Solutions) are bugging patients to take their pills, and increasing pharma company profits into the bargain. And even after digging up David Sobel, John Abramson & Jerry Avorn, the NYT can’t find too much bad to be said about these programs — even though pharma companies are paying for them. Everyone agrees compliance is good, and getting patients to take their pills is hard work.

But I didn’t notice them referring to any compliance programs for generics. Funny that.

White House Letter; An Outspoken Conservative Loses His Place at the Table – The Archive – The New York Times

White House Letter; An Outspoken Conservative Loses His Place at the Table – The Archive – The New York Times

Mr. Bartlett, 54, the author of a syndicated newspaper column and articles in academic journals, was dismissed in October as a senior fellow at the National Center for Policy Analysis, a research group based in Dallas. In the interview, Mr. Bartlett said he had been fired because his increasingly critical comments about Mr. Bush, in his column, in his book and in other publications, had hampered the ability of the research institution to raise money among Republican donors.He also provided a copy of an e-mail message that he said was sent to him in August 2004 by Jeanette Goodman, the vice president of the research institution. ”100K is off the table if you do another ‘dump Cheney’ column and 65K donor is having a rebuttal done, in a national magazine, to your attack on the fair tax people so that 65K may be gone also,” Ms. Goodman wrote about one of Mr. Bartlett’s columns about the vice president. ”Do you have any ideas on where I could raise that amount quickly?”John C. Goodman, the president of the organization and Ms. Goodman’s husband, said in a telephone interview over the weekend that he did not know what his wife had said to Mr. Bartlett and that he did not want to say whether Mr. Bartlett ”did or didn’t hurt fund-raising.” But Mr. Goodman added, ”That’s not why he was fired.”

PHARMA/PHYSICIANS: Reimbursements Sway Oncologists’ Drug Choices, by Greg Pawelski

Greg Pawelski is not exactly surprised about the latest revelations about oncologists and their use of chemotherapy.

A joint Michigan/Harvard study confirms that medical oncologists choose cancer chemotherapy based on how much money the chemotherapy earns the medical oncologist. Just published in the journal Health Affairs is a joint Harvard/Michigan study entitled “Does reimbursement influence chemotherapy treatment for cancer patients?” In a study of 9,357 patients, the authors documented a clear association between reimbursement to the oncologists for the chemotherapy of breast, lung, and colorectal cancer and the regimens which the oncologists selected for the patients. In other words, oncologists tended to base their treatment decisions on which regimen provided the greatest financial remuneration to the oncologist  This study adds to the ‘smoking gun’ study of Dr. Neil Love on the subject. The results of his survey show that for first line chemotherapy of metastatic breast cancer, 84-88% of the academic center-based oncologists prescribed an oral dose drug (capecitabine), while only 13% prescribed infusion drugs, and none of them prescribed the expensive, highly remunerative drug docetaxel. In contrast, among the community-based oncologists, only 18% prescribed the oral dose drug (capecitabine), while 75% prescribed infusion drugs, and 29% prescribed the expensive, highly remunerative drug docetaxel. The existence of this profit motive in drug selection has been one of the major factors working against the individualization of cancer chemotherapy based on testing the cancer biology. Once a decision to give chemo is taken, physicians receiving more-generous Medicare reimbursements used more-costly treatment regimens.

BLOGS: Health Wonk Review

Welcome to Health Wonk Review. Joe expected some crack about English soccer fans, but I’m all depressed since the Catalans ejected my boys with barely a whimper from the European Champions League we were supposed to win on Tuesday.
 
So onto the review. Every two weeks we’re putting together the best of the health care policy, business and technology posts from around the blogosphere, and the hosting will rotate too. We’re going to start with:
 
Politics, policy and voodoo economics
 
The good boys and girls at Marketplace.MD have been busy. Founder Trapier K. Michael gives credit to the free market for hospital quality information on his new blog, Hayek, MD. Evian at Free Canada tells us how "Liberal health policy" makes Alberta’s premiere want to hurl and throw a Russell-Crowe-type health policy fit. And David of Medical Liberty looks at Dr. Wennberg (of Dartmouth Atlas fame) and asks "Where’s the Patient?" in healthcare anymore…You can also check out Marketplace.MD Blog to get your daily dose of health policy blog fodder….but those of you with a liberal bent might want to be ready for a barney!
 
Meanwhile, in many liberal blogs the old debate about single payer
versus other approaches to universal care is getting a run out.  At TPMcafe, Leif Wellington Haase wonders about
"Universal Health Care: Many Roads to Rome?" The piece argues that the
goal of universal coverage can be pursued through many means, not only through
insisting on a "single-payer only" strategy. On the same theme
at SignalHealth John Rodat’s Politics After Single Payer, is a piece about single-payer proponents struggling to reconcile their shared disdain for President Bush and Republican Congressional leadership with their confidence  in complete Federal control of healthcare financing in the US.  John also wrote, "A Tiny Technical Issue of Constitutional Significance" about the Deficit Reduction Act of 2005. The Act had many provisions related to health care, especially Medicare and Medicaid, but John argues that the most important issue is one of legislative procedure, an inconsistency between the House and Senate passed versions of and the cavalier manner in which the political leadership ignored a fundamental rule of lawmaking in the US.
Jonathan Cohn, New Republic health care reporter and author of a forthcoming book on health care sounds the alarm about rationing — the kind that already happens here in the U.S. Don’t look now, he says, but the problem is about to get worse.  
Meanwhile, at Healthy Policy young punkette Kate Steadman mulls over the potential problems of staying in an employer-based insurance framework.
 
There’s plenty more from Jonathan, Kate, Leif, Ezra Klein and plenty of others (including when he gets around to it your host at THCB) over at the “Drug Bill Debacle” table at TPMCafe. Those of you on the “free-market” end of the spectrum (or whatever passes for that these days) may have to gird up your loins before you venture over. I’ll leave the reader to decide whose policy is voodoo-based. 
 
Health care is though as much about business as it is about policy:
 
The business of health care is business
 
Tony Chen of Hospital Impact comments on the supposed 5 most dangerous trends for hospitals.  Could profitability problems close down 150,000 hospital beds in the next 6 years?
 
At Health Care Renewal, Roy Poses has a great article about Shalala and the janitors. To give it all away, the first irony is that the maintenance workers at the University of Miami medical center do not have health insurance provided by their employer. The second is that the university president, whose palatial university-supplied mansion and life-style were just written up in the New York Times Magazine, is Donna Shalala, former Secretary of Health and Human Services in the Clinton administration, a public advocate for universal health insurance. The third (and not noted except on Health Care Renewal) is that Shalala also sits on the board, and hence has fiduciary responsibility for, UnitedHealth Group, a for-profit managed care company whose stated mission includes improving access to health care.
 
David Williams at the Health Business Blog looks at the FDA report on the status of pharma companies’ post-marketing commitments. Although PhRMA says the report shows all is well, Public Citizen makes a solid argument for why that’s not the case.
 
At Managed Care Matters Health Wonk Review’s founder and guiding star Joe Paduda worries that rising health care costs are leading to increasing labor relations problems for manufacturers and service companies across the US. With premiums growing five times faster than wages, employers are trying to shift more of the financial burden onto workers. One of the better reform advocacy groups, the National Coalition for Healthcare Reform, has done an admirable job of presenting alternative solutions.

At Point of Law, insurance specialist Martin Grace of Georgia State looks at some current controversies over medical malpractice and concludes that the recent crisis is not just an artifact of the "insurance cycle", as some have contended; and that the leveling off of premiums in the past year should not be taken as a sign that our medical liability system has somehow reverted to health.

Dmitriy, the Publisher of The Medical Blog Network has looked into the firestorm caused by New York Times article "Why Doctors So Often Get It Wrong", noting that P4P is here to stay and now even AMA is getting with the program.

At THCB your host is not surprised that we have too many inefficient doctors, but predicts an untimely demise for a certain group of health service researchers if they don’t shut up about it. 
 
Meanwhile guesting in the same place, Brian Klepper is unimpressed by the chances of consumerism as being a savior for health care.  Don’t miss the excellent and long, long comments section.
Tech and mash
Some of the best in the health care IT world are in this section:

Shahid Shah, The Healthcare IT Guy, blogs about how we should all start using RSS for health/medical alerts and data sharing. In the posting he reminded us that today’s medical devices send out alerts using push-based approaches which are usually proprietary. He encourages software vendors to start providing RSS/ATOM feeds from their applications to help get non-safety-critical data out of their health IT systems because it’s easier to use, interoperable, and a cinch to deploy.

Tim Gee at Medical Connectivity reports on the creation of a health care advisory board for portable computing device vendor OQO. The OQO “pocketable” Windows computer could be the device that overcomes limitations that have held back the adoption of other devices like PDAs and Tablet computers.

MrHISTalk features an excellent article from Nurse Janus about the hellish life of a clinician going through a major install, and subsequent un-install. And of course most of the best gossip in the hospital IT world lives at that site.

Turning his hand to tech, Dmitriy of The Medical Blog Network reports from the CalRHIO Summit III, making sense of how capable are RHIOs of truly serving the interests of consumers. What is rhetoric and what is reality? He also writes about the tough talk dished out by Craig Barrett towards the healthcare industry and why this is the leading indicator of general public’s attitude towards the industry.

Guesting on THCB, hospital IT director Roy Johnson is not exactly impressed by the “highness” of the tech in health care IT.

Rod, on the Informaticopia Blog examines the implications of an announcement by UK universities that they will be changing their user authentication system from Athens to Shibboleth over the next few years. As the UK’s National Health Service currently uses the Athens system for its 1 million + staff it is likely that they will need to go the same way.

Rod would also like to give everyone a “heads up” about the HC2006 Blog from Europe’s Healthcare Computing Conference and Exhibition (which is sort of equivalent to HIMSS) on 20-22nd March. The blog will be an eclectic collection of news and views – as near to real time as we can get it – and offer the opportunity for those unable to attend to comment on the issues.
Meanwhile, if you are thinking of haranguing a journalist or a blogger about your company’s incredible new software product, Neil Versel’s Healthcare IT Blog tells you what not to do

Odds and ends
 
Last but not least are a few on unique health care issues that don’t fit so easily into other sections
 
Fard Johnmar at Envisioning 2.0 is currently holding a series of conversations about race and medicine with physicians, communicators, health policy experts and others. He is publishing these discussions to highlight new perspectives from a variety of people in the healthcare field about this important issue.  Dr. Sally Guttmacher, a noted public health expert, is the subject of the first interview. Fard will be posting interviews on this subject for the next few weeks — at least.  He is encouraging others within and without the healthcare blogosphere to contact him to be interviewed about this  topic. 
 
Guns at work – coming to a neighborhood near you? Julie Ferguson at Workers Comp Insider discusses the state-by-state push by the NRA to enact legislation that would override an employer’s policy prohibiting employees from keeping guns in their cars on company premises. Such measures have passed in a few states, but have hit a temporary roadblock in Florida. The NRA is determined to push on. The American Journal of Public Health recently published a study finding that murders are three times more likely to occur in workplaces that permit employees to carry weapons than in workplaces that prohibit all weapons.

 
Rita at the MSSP Nexus Blog (and no I still don’t know what that title means) is a little riled up about the practicalities and problems with board certification and credentialing as discussed in a recent JAMA article.
 
Meanwhile in one of my homes, away from THCB  Spot-on,  I’m very upset about the role of the Calvinists in our medicine cabinets. DEA employees reading this may not like what I say about them.

——

Thanks to all those who contributed, especially as I had them do it in a very vicious stringent format which almost everyone kept to. It really cuts down on the hosts work, so I recommend it to future hosts. You can see what I suggested for contributors here.

In two weeks Kate Steadman will  host HRW over at Healthy Policy.

POLICY/HOSPITALS/PHYSICIANS: Wennberg found wearing concrete boots at bottom of Lake Michigan

No, not really. But Wennberg’s disciples at Dartmouth are coming out with so many uncomfortable facts for the medical-industrial complex that it’s hard to keep count. Starting by introducing the notion of practice variation 30 years ago, the group is now turbo-charging its research production, and basically all of it is bad news for anyone pretending that “American health care is the best in the world”. To paraphrase Uwe Reinhardt, how can the American healthcare not be as good as American health care?

In just the last couple of years not only has the Dartmouth crowd found that care delivered in areas with fewer doctors, and using less advanced technology, leads to better outcomes at lower costs, but they’ve also found that academic medical centers vary threefold in their efficiency of inputs (and costs) to get the same outputs, and most recently that hospital system and location is a better indicator of resource use than population acuity.

And, for the medical establishment, the news gets worse. For the last five or so years, those of us who think that we’ve already got plenty of doctors per head, as we doubled the number in medical school in the 1970s and 1980s and are still waiting for the smaller generations trained in the 1960s to retire, have been drowned out by hysteria from the medical establishment about an impending “physician shortage”. That is of course code for the taxpayer (via Medicare which funds most medical education) to support the creation of new physician residency slots, creating more specialists, who’ll then start applying more medical technology to all of us, which will contribute to more flat of the curve medicine. But I won’t give you a potted Fuchs/Enthoven class here (although you can search around plenty in THCB if you want more).

Today in Health Affairs (or you can read the potted version in Forbes), Dartmouth researcher David Goodman and his team (including Wennberg) cry bullshit on the “we need more doctors” meme. While the big academic centers which get the money from training them would love to have more residents, by examining one type of intensive medical process — caring for patients at the end of life in ICUs — Goodman et al shows pretty logically that many major academic centers use far too many physician resources. In other words we could provide equally good (or probably better) care while using many many fewer physician “inputs”. Hence overall we need fewer physicians, more efficiently used.

Of course any English surgeon, whose workloads and consequently surgical speed massively exceed those of their American counterparts, could have told you that. And my father frequently did every time he came back from a “fact-finding” trip over here. And when Goodman et al invoke the most famous name in American medicine, it’s pretty hard to argue with their conclusions:

"We have benchmarks. We have academic medical centers which are highly successful in terms of the care they provide, and we need to start looking to those places as our examples," Goodman said. "We need to study them and understand them and emulate them. The Mayo Clinic has been studied very extensively and is fairly well-understood," he continued. "We should be at a point where we can emulate some of those systems."

Mayo of course has fantastic outcomes at relatively low cost. In this study it used 8.9 physician full-time equivalents per 1,000 patients in the six months before death, while at the other end of the spectrum New York University Medical Center had 28.3. Of course the system-wide implications of all of the Dartmouth research are too awful for the medical establishment to contemplate, because they in the end mean 20 of the 28.3 doctors at NYU going away – and there are enough cab drivers in New York City as it is. And it’s not just New York city doctors that suffer when you extrapolate:

Applying the Rochester standard to the nation’s elderly, the United States has an excess of physician input; it needs 30,163 fewer FTE inputs than were allocated in 2000. Indeed, the current rate of supply growth along with excess capacity is sufficient to accommodate the 56 percent increase (in the number of elderly-MH add) predicted for 2020, with 49,917 physicians to spare.

All this research of course reminds organized medicine, and the industries that feed off its members prescribing more and more technology without caring about the cost, of something Lenin said back in 1923 about “Better fewer but better”. And you know how the American medical establishment hates them commies. On the other hand, it also invites memories similar to what Maggie Thatcher did to the British steel-workers in 1980 — she basically fired 70% of the workforce, but the amount of steel produced stayed the same. Are they going to call Maggie a commie? I think not, but you may have noticed lots of major industries taking the same approach.

So this research will stay ignored. We spend too much on high-tech medicine, we have too many specialists doing too many heroic procedures, and everyone’s very happy about that. Until that is that we notice that we have a health care system that does a shitty job of basic primary care, doesn’t cover 45 million people and costs way too much.

But if word somehow sneaks out that the two sides of that equation might per chance be related, then the pillars of the medical establishment might choose to move to other tactics. And perhaps the Dartmouth crowd might find themselves wearing concrete boots and hanging with Jimmy Hoffa instead.

CODA: And in a quick reminder that doctors are doctors whatever their
passport cover says, this article explains how spending more on health care in
Canada has not
shortened waiting times

In the five years up to 2002-03, the number of angioplasties (to open
arteries) and bypass surgeries increased 51 per cent, the number of joint
replacements rose 30 per cent, and cataract surgeries 32 per cent. But demand
for care seems to have increased just as much, and it’s not just because the
population is aging. "We’ve got way more activity beyond what the demographics
would dictate," said CIHI Chairman Graham Scott:More research is needed
to understand the phenomenon, he said but new technology is probably a factor.
If there are new tools available, such as MRIs, doctors are likely to use them.
If techniques for a certain kind of surgery improve, the procedure will become
more popular.

Duh! They don’t need more research. When the NHS was introduced in
the UK in 1948, the politicians thought that demand would fall after the initial
rush from those who hadn’t had coverage before wound down. But it didn’t. 50
years of data tells us that in health care supply creates its own demand, and
the way to deal with that is to restrict supply.

assetto corsa mods